Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study
2008 · BMC Medicine · 120 citations
https://doi.org/10.1186/1741-7015-6-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
3.9K
Citations
24
h-index
27
i10-index
Thomas Björk is an academic researcher from Skåne University Hospital. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Prostate Cancer Diagnosis and Treatment & Stochastic processes and financial applications. The author has an h-index of 24, co-authored 43 publications.
Click to start Chat